histocompatibility

(redirected from Histocompatibility antigens)
Also found in: Thesaurus, Medical, Encyclopedia.

his·to·com·pat·i·bil·i·ty

 (hĭs′tō-kəm-păt′ə-bĭl′ĭ-tē)
n. pl. his·to·com·pat·i·bil·i·ties
A state or condition in which the absence of immunologic interference permits the grafting of tissue or the transfusion of blood without rejection.

his′to·com·pat′i·ble adj.

histocompatibility

(ˌhɪstəʊkəmˌpætɪˈbɪlɪtɪ)
n
(Biochemistry) the degree of similarity between the histocompatibility antigens of two individuals. Histocompatibility determines whether an organ transplant will be tolerated
ˌhistocomˈpatible adj

his•to•com•pat•i•bil•i•ty

(ˌhɪs toʊ kəmˌpæt əˈbɪl ɪ ti)

n.
the condition of being similar antigenic types such that cells or tissues transplanted from a donor to a recipient are not rejected.
[1945–50]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.histocompatibility - condition in which the cells of one tissue can survive in the presence of cells of another tissue; "a successful graft or transplant requires a high degree of histocompatibility"
organic phenomenon - (biology) a natural phenomenon involving living plants and animals
Translations

his·to·com·pat·i·bil·i·ty

n. histocompatibilidad, estado en el cual los tejidos de un donante son aceptados por el receptor;
major ___ complexcomplejo de ___ mayor.
References in periodicals archive ?
"The rest of those failures are probably due to less common antigens, or so-called minor histocompatibility antigens. However, the identity of most of these antigens and how they lead to rejection is largely not known," said senior co-author Krzysztof Kiryluk.
A single dose of anti-CD45 saporin ADC, when combined with post-transplant cyclophosphamide to prevent graft-versus-host-disease, enabled successful engraftment across minor histocompatibility antigens. The anti-CD45 saporin ADC was more effective than an unconjugated anti-CD45 antibody, pre-transplant cyclophosphamide, or sublethal irradiation in combination with post-transplant cyclophosphamide.
An explanation for the fetal sex-specific difference in mRNA expression of FOXP3 could be the presence of the Y chromosome in males, which encodes minor histocompatibility antigens (HY) [29].